Orencia (abatacept)
Billing
Code: J0129
Description: Abatacept injection
Unit: 10 mg
Payment: $42.700
Pay quarter: Q4 2023
Dosage and Frequency
Rheumatoid Arthritis
• 500mg IV if patient weighs less than 60kg
• 750mg IV if patient weighs 60-100kg
• 1000mg IV if patient weighs greater than 100kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 125mg SQ every 1 week
• 500mg IV if patient weighs less than 60kg
• 750mg IV if patient weighs 60-100kg
• 1000mg IV if patient weighs greater than 100kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 125mg SQ every 1 week
Polyarticular Juvenile Idiopathic Arthritis
• 10mg/kg IV if patient weighs less than 75kg
• Follow dosage for Rheumatoid Arthritis if patient weighs greater than or equal to 75kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 50mg every 1 week if patient weighs 10-25kg
• 87.5mg every 1 week if patient weighs 25-50kg
• 125mg every 1 week if patient weighs greater than 50kg
• 10mg/kg IV if patient weighs less than 75kg
• Follow dosage for Rheumatoid Arthritis if patient weighs greater than or equal to 75kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 50mg every 1 week if patient weighs 10-25kg
• 87.5mg every 1 week if patient weighs 25-50kg
• 125mg every 1 week if patient weighs greater than 50kg
Psoriatic Arthritis (PsA)
• 500mg IV if patient weighs less than 60kg
• 750mg IV if patient weighs 60-100kg
• 1000mg IV if patient weighs greater than 100kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 125mg SQ every 1 week
• 500mg IV if patient weighs less than 60kg
• 750mg IV if patient weighs 60-100kg
• 1000mg IV if patient weighs greater than 100kg
Induction:
• at weeks 0, 2, and 4
Maintenance:
• every 4 weeks
OR
• 125mg SQ every 1 week
prophylaxis of acute graft versus host disease (aGVHD)
For patients aged 6 years or older
• 10mg/kg IV (not to exceed 1000mg) on day before transplantation, and days 5, 14, and 28 after transplantation
For patients aged 2-6 years
• 15mg/kg IV on day before transplantation
• 12mg/kg IV on days 5, 14, and 28 after transplantation
For patients aged 6 years or older
• 10mg/kg IV (not to exceed 1000mg) on day before transplantation, and days 5, 14, and 28 after transplantation
For patients aged 2-6 years
• 15mg/kg IV on day before transplantation
• 12mg/kg IV on days 5, 14, and 28 after transplantation
Calculate drug reimbursement
Total Reimbursement:
$3,202.50(ASP: $3,021.23, Margin: $181.27)
Code:
J0129# Units to bill:
75Prior Authorization
Prior auth criteria for Orencia may include but is not limited to:
• Patient must have a diagnosis of active rheumatoid arthritis that has been confirmed by x-ray, MRI, or other appropriate clinical laboratory test.
• Patient must have an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) or have a contraindication to or intolerance of DMARDs.
• Patient must have a high disease activity as measured by C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR).
• Patient must have a score of ? 6 on the American College of Rheumatology (ACR) 20 criteria.
• Patient must have evidence of joint destruction on x-ray.
• Patient must not have a history of tuberculosis (TB) or other serious infections.
• Patient must not have a history of hypersensitivity to abatacept or any of the components of the Orencia formulation.
Insurance prior auth guidelines:
Billable NDCs
00003-2187-10
Abatacept (BRISTOL-MYERS SQUIBB COMPANY)
250 MG
00003-2187-13
ORENCIA (BRISTOL-MYERS SQUIBB COMPANY)
250 MG
00003-2188-11
ORENCIA (BRISTOL-MYERS SQUIBB COMPANY)
500 MG
00003-2188-51
ORENCIA CLICKJECT (BRISTOL-MYERS SQUIBB COMPANY)
500 MG
00003-2814-11
ORENCIA (BRISTOL-MYERS SQUIBB COMPANY)
200 MG
00003-2818-11
ORENCIA (BRISTOL-MYERS SQUIBB COMPANY)
350 MG
Resources